CHAPTER 1 INTRODUCTION
1.1. Market Definition
1.2. Executive Summary
1.3. The Scope of the Study
CHAPTER 2 RESEARCH METHODOLOGY
2.1. Secondary Research
2.2. Primary Research
2.3. Analytic Tools and Model
2.4. Economic Indicator
2.4.1. Base Year, Base Currency, Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
CHAPTER 3 MARKET ANALYSIS
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1. Bargaining Power of Buyers
3.2.2. Bargaining Power of Suppliers
3.2.3. Threats of Substitutes
3.2.4. Threats of New Entrants
3.2.5. Degree of Competition
3.3. PESTLE Analysis
3.3.1. Political
3.3.2. Economical
3.3.3. Social
3.3.4. Technological
3.3.5. Legal
3.3.6. Environmental
3.4. SWOT Analysis
3.4.1. Strengths
3.4.2. Weakness
3.4.3. Opportunities
3.4.4. Threats
3.5. Y-O-Y Analysis
CHAPTER 4 MARKET DYNAMICS
4.1. Market Drivers & Opportunities
4.1.1. Increasing awareness about early detection of breast cancer
4.1.2. Rapidly increasing aging population and the growing prevalence of breast cancer
4.1.3. Government investments and funding for breast cancer treatment and related research
4.1.4. The launch of advanced systems capable of detecting cancer in women with dense breast tissue
4.1.5. Technological advancements in breast imaging modalities
4.1.6. Technological innovations in breast cancer detection & emerging economies offer high growth potential
4.2. Market Restraints & Challenges
4.2.1. Errors in breast cancer screening and diagnosis coupled with side effects of radiation exposure
4.2.2. Stringent regulatory approval procedures and unfavourable reimbursement scenario in developing economies
4.2.3. High installation costs of breast imaging systems
CHAPTER 5 GLOBAL BREAST IMAGING MARKET – BY TYPE
5.1. Non-Ionizing Technologies
5.1.1. Automated Whole-Breast Ultrasound
5.1.2. Breast Thermography
5.1.3. Optical Imaging
5.1.4. Breast Ultrasound
5.1.5. Breast MRI
5.2. Ionizing Technologies
5.2.1. Cone-Beam Computed Tomography
5.2.2. Molecular Breast-Specific Gamma Imaging
5.2.3. Positron Emission Mammography
5.2.4. Electric Impedance Tomography
5.2.5. Full-Field Digital Mammography
5.2.6. Analog Mammography
5.2.7. 3D Breast Tomosynthesis
5.2.8. Positron Emission Tomography and Computed Tomography
CHAPTER 6 GLOBAL BREAST IMAGING MARKET - BY GEOGRAPHY
6.1. Introduction
6.2. North America
6.2.1. U.S.
6.2.2. Canada
6.2.3. Mexico
6.2.4. Costa Rica
6.3. South America
6.3.1. Brazil
6.3.2. Argentina
6.3.3. Chile
6.3.4. Columbia
6.3.5. Others
6.4. Europe
6.4.1. U.K.
6.4.2. Germany
6.4.3. France
6.4.4. Italy
6.4.5. Spain
6.4.6. Russia
6.4.7. Netherlands
6.4.8. Switzerland
6.4.9. Poland
6.4.10. Others
6.5. Asia Pacific
6.5.1. China
6.5.2. Japan
6.5.3. India
6.5.4. South Korea
6.5.5. Australia & New Zealand
6.5.6. Malaysia
6.5.7. Singapore
6.5.8. Others
6.6. Middle East & Africa
6.6.1. UAE
6.6.2. Saudi Arabia
6.6.3. Iran
6.6.4. Iraq
6.6.5. Qatar
6.6.6. South Africa
6.6.7. Algeria
6.6.8. Morocco
6.6.9. Nigeria
6.6.10. Egypt
6.6.11. Others
CHAPTER 7 GLOBAL BREAST IMAGING MARKET - COMPANY PROFILES
7.1. Gamma Medica, Inc.
7.2. Toshiba Corporation
7.3. Sonociné, Inc.
7.4. Aurora Imaging Technology, Inc.
7.5. Dilon Technologies, Inc.
7.6. General Electric Company
7.7. Siemens AG
7.8. Koninklijke Philips N.V.
7.9. Hologic, Inc.
7.10. Fujifilm Holdings Corporation
7.11. Dilon Technologies Inc.
7.12. Barco NV
7.13. Thorlabs Inc.
CHAPTER 8 GLOBAL BREAST IMAGING MARKET – COMPETITIVE
LANDSCAPE
8.1. Market Share Analysis
8.2. Strategies adopted by top companies
8.3. Mergers, Acquisitions, Collaborations & Agreements
CHAPTER 9 MARKET INSIGHTS
9.1. Industry Experts Insights
9.2. Analysts Opinions
9.3. Investment Opportunities
CHAPTER 10 APPENDIX
10.1. List of Tables
10.2. List of Figures
